Ultragenyx Pharmaceutical Inc. (RARE) SEC Filings — 2025
20 SEC filings for Ultragenyx Pharmaceutical Inc. (RARE) in 2025.
Filings
- Ultragenyx Pharmaceutical Inc. 8-K Filing — 8-K · Dec 30, 2025
- Ultragenyx Pharmaceutical Inc. 8-K Filing — 8-K · Dec 29, 2025
- Ultragenyx Losses Widen on Soaring R&D, Revenue Growth Continues — 10-Q · Nov 5, 2025
- Ultragenyx Pharmaceutical Inc. 8-K Filing — 8-K · Nov 4, 2025
- Ultragenyx Pharmaceutical Inc. Files 8-K — 8-K · Oct 30, 2025
- Ultragenyx Pharmaceutical Inc. Files 8-K — 8-K · Sep 8, 2025
- Ultragenyx Pharmaceutical Inc. Files 8-K — 8-K · Aug 18, 2025
- Ultragenyx Narrows Q2 Loss on Strong Product Sales Growth — 10-Q · Aug 6, 2025
- Ultragenyx Pharmaceutical Files 8-K on Financials — 8-K · Aug 5, 2025
- Ultragenyx Pharmaceutical Inc. Files 8-K — 8-K · Jul 31, 2025
- Ultragenyx Pharmaceutical Inc. Files 8-K — 8-K · Jul 11, 2025
- Ultragenyx Pharmaceutical Inc. Files 8-K — 8-K · Jul 9, 2025
- Ultragenyx Pharmaceutical Inc. Files 8-K — 8-K · Jun 27, 2025
- Ultragenyx Pharmaceutical Inc. Reports Director and Officer Changes — 8-K · May 19, 2025
- Ultragenyx Pharmaceutical Inc. Files Q1 2025 10-Q — 10-Q · May 7, 2025
- Ultragenyx Pharmaceutical Files 8-K on Financials — 8-K · May 6, 2025
- Ultragenyx Files 2025 Proxy Statement — DEF 14A · Mar 28, 2025
- Ultragenyx Pharmaceutical Inc. Files 2024 10-K — 10-K · Feb 19, 2025
- Ultragenyx Pharmaceutical Inc. Files 8-K — 8-K · Feb 13, 2025
- Ultragenyx Pharmaceutical Inc. Files 8-K — 8-K · Jan 13, 2025